Table 2.
Basal characteristics of infertile couples
| Control | 1, 9, 16qh+/− group | D/G group | inv(9) | P value | |
|---|---|---|---|---|---|
| No. of case | 1088 | 129 | 56 | 62 | |
| Female age (years) | 30.88 ± 3.23 | 31.35 ± 4.43 | 30.91 ± 4.03 | 31.04 ± 4.56 | 0.799 |
| BMI of women (kg/m2) | 22.39 ± 3.16 | 22.05 ± 3.61 | 22.65 ± 3.50 | 22.76 ± 3.56 | 0.509 |
| Duration of infertility (years) | 4.3 ± 3.09 | 5.14 ± 3.66 | 4.75 ± 2.87 | 4.78 ± 3.37 | 0.803 |
| Baseline FSH (IU/L) | 6.68 ± 1.79 | 6.63 ± 2.13 | 6.52 ± 1.61 | 6.73 ± 1.81 | 0.159 |
| Male carrier (%) | - | 74 (57.4) | 32 (57.1) | 25 (40.3) | 0.068 |
| Female carrier (%) | - | 55 (42.6) | 24 (42.9) | 37 (59.7) | |
| Long protocol (%) | 914(77.33) | 98 (75.97) | 41 (73.21) | 46 (74.19) | 0.838 |
| GnRH antagonist protocol (%) | 268(22.67) | 31 (24.03) | 15 (26.79) | 16 (25.81) | |
| IVF (%) | 908(83.5) | 90 (69.8) | 34 (60.7) | 44 (71.0) | 0.014 |
| ICSI (%) | 180(16.5) | 39 (30.2) | 22 (39.3) | 18 (29.0) | |
| Duration of Gn (days) | 10.25 ± 1.82 | 10.13 ± 1.65 | 10.38 ± 1.64 | 10.50 ± 2.69 | 0.142 |
| Starting Gn dose (IU) | 192.89 ± 38.98 | 196.97 ± 45.21 | 194.53 ± 41.89 | 196.97 ± 45.22 | 0.360 |
| Total Gn ampoules(75 IU) | 28.69 ± 9.98 | 29.00 ± 10.76 | 27.92 ± 8.89 | 30.32 ± 14.22 | 0.355 |
| E2 level on HCG day (pg/mL) | 4286.67 ± 2202.32 | 3899.19 ± 2204.88 | 4421.89 ± 2748.18 | 3988.46 ± 2417.62 | 0.139 |
| Thickness of endometrium on HCG day (mm) | 1.05 ± 0.21 | 1.03 ± 0.21 | 1.09 ± 0.22 | 1.06 ± 0.21 | 0.206 |
| Progesterone | 1.14 ± 0.57 | 1.10 ± 0.51 | 1.05 ± 0.45 | 1.13 ± 0.53 | 0.206 |
Values are number (or percentage). P value < 0.05 was considered to be significantly. All continuous variables are expressed as mean ± SD
BMI body mass index, FSH follicle stimulating hormone, GnRH gonadotropin-releasing hormone, IVF in vitro fertilization, ICSI intracytoplasmic sperm injection, Gn gonadotropin, HCG human chorionic gonadotropin, E2 estradiol